Study data suggests IGV-001 provides patients with a clinically meaningful improvement in overall survival (+6.3 months; +45%) compared to the current standard of care for ndGBM –– Company plans to ...
Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the ...
Tema ETFs (“Tema”), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (“CANC”) has surpassed $100m in assets under management (AUM) ...
UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI Industry hopes ...
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial OfficerOslo, Norway, 28 November 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell ...
New insights into NHS prescribing for care home patients aged 65 and over released27 November 2025An estimated 331,000 care home patients aged 65+ received NHS prescriptions on average each month in ...
Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting· New data to be presented at the 2025 ...
This press release is provided in English and German.Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity ZURICH, Switzerland, December 01, ...
DOWNERS GROVE, IL / ACCESS Newswire / December 2, 2025 / Dr. Sarah Martin, a women's urology specialist at Duly Health and Care's Chicagoland medical group, DuPage Medical Group, Ltd., this month ...
The global medical equipment maintenance market is expected to grow at a compound annual growth rate (CAGR) of 8-10% over the ...
Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron®-- New Synthetic Process to be Used for Phase 3 Development Provides Higher Manufacturing Yields and Reduces Costs Versus ...
New U.S. Patent Extends Protection Through 2042 ~~ Patent Allowance Secures Highest Level of Intellectual Property Protection for MPAR® ~ SAN DIEGO, CA / ACCESS Newswire / December 2, 2025 / Ensysce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback